Copilot
Il tuo AI Companion quotidiano
Informazioni sui risultati di 401
  1. acs.org
    https://testpubschina.acs.org/doi/10.1021/acs.biomac.6b00146

    Adsorption of Plasma Proteins onto PEGylated Lipid Bilayers: The …

  2. SAGE Journals
    https://journals.sagepub.com/doi/full/10.1177/08853282241258304

    Comparative study of iodine-doped and undoped pyrrole grafting …

  3. Le persone hanno chiesto anche
    Can ngp-3 encapsulated in PLGA nanoparticles be used to treat tumors?
    Furthermore, their research demonstrated that systemic administration of NGP-3 encapsulated within tumor-targeting poly (lactic-co-glycolic acid) (PLGA) nanoparticles proved to be an effective method for delivering the drug to subcutaneous tumor sites.

    New-generation advanced PROTACs as potential therapeutic agents in

    molecular-cancer.biomedcentral.com
    Why do nanoparticles have hydrophilic PEG segments?
    The presence of the hydrophilic PEG segment on the surface of the nanoparticles enhances their stability in the bloodstream, preventing rapid clearance by immune cells. As a result, NGP-57 can circulate for extended periods, increasing their chances of reaching tumor tissues.

    New-generation advanced PROTACs as potential therapeutic agents in

    molecular-cancer.biomedcentral.com
    Can ligand modification improve cell permeability in PROTAC prodrugs?
    This targeted delivery approach holds great potential for overcoming poor cell permeability issues commonly encountered with traditional small-molecule drugs. Furthermore, ligand modification also allows for responsive release features in these PROTAC prodrugs.

    New-generation advanced PROTACs as potential therapeutic agents in

    molecular-cancer.biomedcentral.com
    How do hypoxia activated leaving groups (halgs) affect EGFR PROTAC synthesis?
    To achieve this, they introduced hypoxia activated leaving groups (HALGs) into the 4-NH position of a gefitinib-based EGFR PROTAC, resulting in the synthesis of precursors NGP-31 (Fig. 13 B) and NGP-32 (Fig. 13 B).

    New-generation advanced PROTACs as potential therapeutic agents in

    molecular-cancer.biomedcentral.com
    Feedback
  4. Semantic Scholar
    https://www.semanticscholar.org/paper/Comparative-Pharmacokinetic...

    Comparative Pharmacokinetic Study of Standard Astaxanthin and …

  5. Molecular Cancer
    https://molecular-cancer.biomedcentral.com/articles/10.1186/s12943-024...

    New-generation advanced PROTACs as potential therapeutic …

  6. Springer
    https://link.springer.com/article/10.1007/s00289-024-05305-x

    Fabrication and in vitro characterization of nisin-incorporated …

  7. MDPI
    https://www.mdpi.com/2073-4360/16/11/1460

    Preparation and Performance Study of Boron Adsorbent from …

  8. ScienceDirect
    https://www.sciencedirect.com/science/article/abs/pii/S1383586624016563

    Rapid attainment of full wettability through surface PEGylation of ...

  9. ACS Publications
    https://pubs.acs.org/doi/10.1021/acsomega.4c00260

    Construction of an Interfacial Layer of Aramid Fibers Grafted with ...

  10. acs.org
    https://testpubschina.acs.org/doi/10.1021/acsami.7b05912

    Surface PEG Grafting Density Determines Magnetic Relaxation …

  11. Springer
    https://link.springer.com/article/10.1007/s00238-024-02190-5

    Use of platelet-rich plasma and platelet-rich fibrin in burn wound ...

  13. Alcuni risultati sono stati rimossi